| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:Ataquimas
CAS:586348-21-2
Purity:100% Package:1mg/RMB 231;5mg/RMB 470;10mg/RMB 672
|
| Company Name: |
Suzhou Zhixin Biotechnology Co., Ltd.
|
| Tel: |
0512-65118909 18100677375 |
| Email: |
sales@szzxbio.com |
| Products Intro: |
Product Name:Ataquimas
CAS:586348-21-2
Purity:98%+ Package:1g;10g;100g
|
2(1H)-Quinoxalinone,1-ethyl-3-(methylamino)-(9CI) manufacturers
- Ataquimas
-
- $33.00 / 1mg
-
2026-01-04
- CAS:586348-21-2
- Min. Order:
- Purity: 100.00%
- Supply Ability: 10g
|
| | 2(1H)-Quinoxalinone,1-ethyl-3-(methylamino)-(9CI) Basic information |
| | 2(1H)-Quinoxalinone,1-ethyl-3-(methylamino)-(9CI) Chemical Properties |
| Melting point | 137-138 °C(Solv: ethanol (64-17-5)) | | Boiling point | 335.8±25.0 °C(Predicted) | | density | 1.20±0.1 g/cm3(Predicted) | | pka | 1.42±0.20(Predicted) |
| | 2(1H)-Quinoxalinone,1-ethyl-3-(methylamino)-(9CI) Usage And Synthesis |
| Uses | Ataquimast free base is a COX-2 inhibitor that inhibits the release of leukotrienes, TNF-α and GM-CSF. Ataquimast free base can be used in the study of advanced receptor-positive breast cancer[1]. | | References | [1] Kobayashi Y, et al., Highly efficient synthesis of quinoxalinone-N-oxide via tandem nitrosation/aerobic oxidative C-N bond formation. Org Lett. 2011 Dec 2;13(23):6280-3. DOI:10.1021/ol202760c
[2] Kobayashi Y, et al. Highly efficient synthesis of quinoxalinone-N-oxide via tandem nitrosation/aerobic oxidative C-N bond formation. Org Lett. 2011 Dec 2;13(23):6280-3. DOI:10.1021/ol202760c |
| | 2(1H)-Quinoxalinone,1-ethyl-3-(methylamino)-(9CI) Preparation Products And Raw materials |
|